Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger

• Published in: Nature communications Vol. 13; no. 1; p. 976
• Main Authors: Arzika, Ahmed M., Maliki, Ramatou, Goodhew, E. Brook, Rogier, Eric, Priest, Jeffrey W., Lebas, Elodie, O’Brien, Kieran S., Le, Victoria, Oldenburg, Catherine E., Doan, Thuy, Porco, Travis C., Keenan, Jeremy D., Lietman, Thomas M., Martin, Diana L., Arnold, Benjamin F.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 21.02.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 631/250/2152/2153/1291; 692/308/174; 692/308/3187; Anti-Bacterial Agents - administration & dosage; Antibiotics; Antibodies; Azithromycin; Azithromycin - administration & dosage; Campylobacter; Campylobacter Infections - blood; Campylobacter Infections - immunology; Campylobacter Infections - mortality; Campylobacter Infections - prevention & control; Child; Child Mortality; Child, Preschool; Children; Complications; Cryptosporidiosis - blood; Cryptosporidiosis - immunology; Cryptosporidiosis - mortality; Cryptosporidiosis - parasitology; Drug Resistance, Bacterial; Escherichia coli Infections - blood; Escherichia coli Infections - immunology; Escherichia coli Infections - mortality; Escherichia coli Infections - prevention & control; Follow-Up Studies; Giardiasis - blood; Giardiasis - immunology; Giardiasis - mortality; Giardiasis - parasitology; Humanities and Social Sciences; Humans; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulin G - immunology; Infant; Infections; Malaria; Malaria - blood; Malaria - immunology; Malaria - mortality; Malaria - parasitology; Mass distribution; Mass Drug Administration; Microbiomes; Mortality; multidisciplinary; Niger - epidemiology; Pathogens; Placebos; Reduction; Rural Population - statistics & numerical data; Salmonella Infections - blood; Salmonella Infections - immunology; Salmonella Infections - mortality; Salmonella Infections - prevention & control; Science; Science (multidisciplinary); Serology; Vector-borne diseases; Niger
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-022-28565-5

The MORDOR trial in Niger, Malawi, and Tanzania found that biannual mass distribution of azithromycin to children younger than 5 years led to a 13.5% reduction in all-cause mortality (NCT02048007). To help elucidate the mechanism for mortality reduction, we report IgG responses to 11 malaria, bacterial, and protozoan pathogens using a multiplex bead assay in pre-specified substudy of 30 communities in the rural Niger placebo-controlled trial over a three-year period ( n  = 5642 blood specimens, n  = 3814 children ages 1–59 months). Mass azithromycin reduces Campylobacter spp. force of infection by 29% (hazard ratio = 0.71, 95% CI: 0.56, 0.89; P  = 0.004) but serological measures show no significant differences between groups for other pathogens against a backdrop of high transmission. Results align with a recent microbiome study in the communities. Given significant sequelae of Campylobacter infection among preschool aged children, our results support an important mechanism through which biannual mass distribution of azithromycin likely reduces mortality in Niger. In a randomized placebo-controlled trial in rural Niger, biannual azithromycin distribution to children 1-59 months reduced all-cause mortality. Based on serology, Arzika et al . here report a reduction of Campylobacter infection, supporting one mechanism for the intervention’s impact on mortality.